NCT03555591View on ClinicalTrials.gov

"Specified Drug-Use Survey of Trelagliptin Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus"

CompletedOBSERVATIONAL
Enrollment

3,198

Participants

Timeline

Start Date

May 1, 2016

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2021

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Trelagliptin

Trelagliptin tablets

Trial Locations (1)

Unknown

Takeda Selected Site, Tokyo

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT03555591 - "Specified Drug-Use Survey of Trelagliptin Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus" | Biotech Hunter | Biotech Hunter